World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
19647
World Ranking
4103
National Ranking
1870

Arash Grakoui publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arash Grakoui sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 127 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arash Grakoui D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arash Grakoui sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arash Grakoui is affiliated with Emory University School of Medicine in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on immunology, hepatology, infectious diseases, epidemiology, and molecular biology.

The scientist's work covers several main topics, including:

  • Hepatitis C virus research
  • SARS-CoV-2 and COVID-19 research
  • Immune cell function and interaction
  • COVID-19 clinical research studies
  • T-cell and B-cell immunology
  • Liver disease diagnosis and treatment
  • Monoclonal and polyclonal antibodies research

Frequent publication venues for Arash Grakoui include bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, Hepatology, Nature Communications, and Journal of Clinical Investigation.

Selected recent papers authored or co-authored by the scientist include:

  • "Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders," 2020, Gastroenterology
  • "Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures," 2020, Journal of Virology
  • "mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant," 2022, Cell Reports Medicine
  • "Structural insights into hepatitis C virus receptor binding and entry," 2021, Nature
  • "Immune system control of hepatitis C virus infection," 2020, Current Opinion in Virology

Collaborations are a significant component of Grakoui's research, with frequent co-authors including Mehul S. Suthar, Eduardo Salinas, Abigail Vanderheiden, Fengzhi Jin, and Elizabeth J. Elrod.

Best Publications

  • The Immunological Synapse: A Molecular Machine Controlling T Cell Activation

    Arash Grakoui;Shannon K. Bromley;Cenk Sumen;Mark M. Davis

  • Expression and identification of hepatitis C virus polyprotein cleavage products.

    Arash Grakoui;C. Wychowski;C. Lin;S. M. Feinstone

  • HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

    Arash Grakoui;Naglaa H Shoukry;David John Woollard;Jin-Hwan Han

  • Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.

    A Grakoui;D W McCourt;C Wychowski;S M Feinstone

  • Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics

    Tobias Marcello;Arash Grakoui;Giovanna Barba-Spaeth;Erica S. Machlin

  • Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection

    Naglaa H. Shoukry;Arash Grakoui;Michael Houghton;David Y. Chien

  • A second hepatitis C virus-encoded proteinase.

    Arash Grakoui;David W. McCourt;Czeslaw Wychowski;Stephen M. Feinstone

  • Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

    Henry Radziewicz;Chris C. Ibegbu;Marina L. Fernandez;Kimberly A. Workowski

  • Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

    Glenn Randall;Arash Grakoui;Charles M. Rice

  • Glucagon‐like peptide‐1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

    Nitika Arora Gupta;Jamie Mells;Richard M. Dunham;Arash Grakoui

  • Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

    Daniel M. Chopyk;Arash Grakoui;Arash Grakoui

  • HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

    M J Koziel;D Dudley;N Afdhal;A Grakoui

  • Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication

    Kristi L. Berger;Jacob D. Cooper;Nicholas S. Heaton;Rosa Yoon

  • Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.

    Chao Lin;B. M. Pragai;A. Grakoui;Jian Xu

  • Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

    T J Chambers;A Grakoui;C M Rice

  • Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.

    M Battegay;J Fikes;A M Di Bisceglie;P A Wentworth

  • Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes

    Unknown

  • Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.

    Abigail Vanderheiden;Philipp Ralfs;Philipp Ralfs;Tatiana Chirkova;Amit A. Upadhyay;Amit A. Upadhyay

  • Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

    Abdul Ghafoor Khan;Jillian Whidby;Matthew T. Miller;Hannah Scarborough

  • mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

    Unknown

  • Cas9-mediated targeting of viral RNA in eukaryotic cells

    Aryn A. Price;Timothy R. Sampson;Hannah K. Ratner;Arash Grakoui

  • Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)

    Michael J. Fuller;Benoit Callendret;Baogong Zhu;Gordon J. Freeman

Frequent Co-Authors

Christopher M. Walker
Christopher M. Walker The Ohio State University
Mehul S. Suthar
Mehul S. Suthar Emory University
Steven E. Bosinger
Steven E. Bosinger Emory University
Charles M. Rice
Charles M. Rice Rockefeller University
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Cheng Zhu
Cheng Zhu Georgia Institute of Technology
Rafi Ahmed
Rafi Ahmed Emory University
Gordon J. Freeman
Gordon J. Freeman Harvard University
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
François-Loïc Cosset
François-Loïc Cosset Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Accelerated nursing programs offer a solid foundation for those aiming to work in clinical settings quickly. Finding absn programs with high acceptance rates can help prospective students identify accessible pathways into nursing.

Similarly, for those starting their healthcare journey, looking into easy lpn programs to get into is beneficial. Licensed Practical Nurse programs allow for entering the workforce promptly, while providing essential experience relevant to immunology-based care.

As students progress, understanding what is the easiest np program can guide them toward advanced practice roles. Nurse Practitioner degrees enhance clinical skills and open up specialized fields including immunology, infectious diseases, and patient management.

For those interested in mental health, the best pmhnp programs combine psychiatric expertise with nursing practice, integrating immunological knowledge in treating neuroimmune and psychiatric conditions.

By exploring these related online degrees and career pathways, students can tailor their education to meet their professional goals in the evolving landscape of immunology and healthcare.

Best Scientists Citing Arash Grakoui

Trending Scientists

Recently Published Articles